OneMedNet Corporation
ONMD · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.11 | -0.01 | 0.07 | -0.27 |
| FCF Yield | -3.88% | -10.89% | -10.60% | -5.42% |
| EV / EBITDA | -55.18 | 7.00 | -13.87 | -20.12 |
| Quality | ||||
| ROIC | 63.88% | 60.29% | 24.98% | 39.57% |
| Gross Margin | -131.07% | -155.48% | -163.50% | -200.00% |
| Cash Conversion Ratio | 2.10 | -0.77 | 1.02 | 0.85 |
| Growth | ||||
| Revenue 3-Year CAGR | -35.58% | -36.61% | -34.19% | -32.22% |
| Free Cash Flow Growth | 31.88% | -17.10% | 5.29% | -7.85% |
| Safety | ||||
| Net Debt / EBITDA | 0.21 | 0.09 | -3.97 | -3.70 |
| Interest Coverage | -372.50 | -93.77 | -71.74 | -98.74 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 295.93 | 147.48 | -1,550.48 | -6,613.85 |